Delivery Order SPE2DB20D1004-SPE2DB22FF5J0
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FS24B) for Lantus Solostar 100 unit/mL 3mL valued at $1,202.19. The award was made by the Defense Logistics Agency (DLA) on March 29, 2022, with a completion date of March 30, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order for 4,561,309,731 units of Lantus Solostar 100 unit/mL 3mL. The $1,316.58 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a performance location in Conshohocken, PA. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen is a major pharmaceutical distributor that holds significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,940.64 for the pharmaceutical product Lantus Solostar 100 Unit/mL 3mL. The award was made by the Defense Logistics Agency (DLA), a defense agency, on May 26, 2022, with a completion date of May 27, 2022. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order with a ceiling value of $1,975.76 for the supply of Lantus Solostar 100 unit/mL 3mL. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 14, 2023. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a delivery order valued at $1,242.64 for the provision of Lantus Solostar 100 unit/mL 3mL medication. The award was made by the Defense Logistics Agency (DLA), a defense agency, on September 29, 2021, with a completion date of September 30, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,810.86 for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on October 12, 2021, with an ultimate completion date of October 13, 2021. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,179.87 for the pharmaceutical product Lantus Solostar 100 unit/ml 3ml. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 16, 2024. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical distributor, holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,555,366,708 units of Lantus Solostar 100 unit/mL 3mL. The $1,424.64 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,187.60 for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 5, 2023. The contract is a Firm Fixed Price arrangement and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp, as a major...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order awarded by the Defense Logistics Agency (DLA) with a ceiling value of $1,607.05. The contract, with a period of performance through September 6, 2023, is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a medication used to treat diabetes. The contract is a firm-fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB22FF5J0Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FF5J0) valued at $1,263.18 for the supply of 4556938688 units of Lantus Solostar 100 Unit/mL 3mL. The contract was awarded on April 19, 2022 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 20, 2022. The contract is a firm fixed price arrangement and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is one of numerous orders placed under that larger IDC contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/19/22 |